These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31264003)

  • 1. Utility of High Resolution NMR Methods to Probe the Impact of Chemical Modifications on Higher Order Structure of Monoclonal Antibodies in Relation to Antigen Binding.
    Majumder S; Saati A; Philip S; Liu LL; Stephens E; Rouse JC; Alphonse Ignatius A
    Pharm Res; 2019 Jul; 36(9):130. PubMed ID: 31264003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterization of higher order structure changes in methionine oxidized monoclonal antibodies via NMR chemometric analysis and biophysical approaches.
    Li M; Beaumont VA; Akbar S; Duncan H; Creasy A; Wang W; Sackett K; Marzilli L; Rouse JC; Kim HY
    MAbs; 2024; 16(1):2292688. PubMed ID: 38117548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies.
    Majumder S; Jones MT; Kimmel M; Alphonse Ignatius A
    Pharm Res; 2018 Sep; 35(11):220. PubMed ID: 30255351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Characterization of Relationship Between Higher-Order Structure and FcRn Binding Affinity of Stress-Exposed Monoclonal Antibodies.
    Tsuchida D; Yamazaki K; Akashi S
    Pharm Res; 2016 Apr; 33(4):994-1002. PubMed ID: 26694753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Higher Order Structural Changes of a Thermally Stressed Monoclonal Antibody via Mass Spectrometry Footprinting and Other Biophysical Approaches.
    Lin Y; Moyle AB; Beaumont VA; Liu LL; Polleck S; Liu H; Shi H; Rouse JC; Kim HY; Zhang Y; Gross ML
    Anal Chem; 2023 Nov; 95(46):16840-16849. PubMed ID: 37933954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics.
    Brinson RG; Marino JP; Delaglio F; Arbogast LW; Evans RM; Kearsley A; Gingras G; Ghasriani H; Aubin Y; Pierens GK; Jia X; Mobli M; Grant HG; Keizer DW; Schweimer K; Ståhle J; Widmalm G; Zartler ER; Lawrence CW; Reardon PN; Cort JR; Xu P; Ni F; Yanaka S; Kato K; Parnham SR; Tsao D; Blomgren A; Rundlöf T; Trieloff N; Schmieder P; Ross A; Skidmore K; Chen K; Keire D; Freedberg DI; Suter-Stahel T; Wider G; Ilc G; Plavec J; Bradley SA; Baldisseri DM; Sforça ML; Zeri ACM; Wei JY; Szabo CM; Amezcua CA; Jordan JB; Wikström M
    MAbs; 2019 Jan; 11(1):94-105. PubMed ID: 30570405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.
    Cao M; Mo WD; Shannon A; Wei Z; Washabaugh M; Cash P
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):490-507. PubMed ID: 27091886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of NMR and Chemometric Analyses to Better Understand the Quality Attributes in pH and Thermally Degraded Monoclonal Antibodies.
    Beaumont VA; Liu L; Shi H; Rouse JC; Kim HY
    Pharm Res; 2023 Oct; 40(10):2457-2467. PubMed ID: 37798537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlated analytical and functional evaluation of higher order structure perturbations from oxidation of NISTmAb.
    Solomon TL; Delaglio F; Giddens JP; Marino JP; Yu YB; Taraban MB; Brinson RG
    MAbs; 2023; 15(1):2160227. PubMed ID: 36683157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.
    Huang L; Lu J; Wroblewski VJ; Beals JM; Riggin RM
    Anal Chem; 2005 Mar; 77(5):1432-9. PubMed ID: 15732928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling study of long-term stability of the monoclonal antibody infliximab and biosimilars using liquid-chromatography-tandem mass spectrometry and size-exclusion chromatography-multi-angle light scattering.
    Legrand P; Dufaÿ S; Mignet N; Houzé P; Gahoual R
    Anal Bioanal Chem; 2023 Jan; 415(1):179-192. PubMed ID: 36449030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion.
    Wang Y; Li X; Liu YH; Richardson D; Li H; Shameem M; Yang X
    MAbs; 2016; 8(8):1477-1486. PubMed ID: 27598507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of in vivo site-specific Asp isomerization and Asn deamidation of mAbs in animal serum using IP-LC-MS.
    Mehl JT; Sleczka BG; Ciccimaro EF; Kozhich AT; Gilbertson DG; Vuppugalla R; Huang CS; Stevens B; Mo J; Deyanova EG; Wang Y; Huang RY; Chen G; Olah TV
    Bioanalysis; 2016 Aug; 8(15):1611-1622. PubMed ID: 27397670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the conformational impact of chemical modifications on monoclonal antibodies with diverse sequence variation using hydrogen/deuterium exchange mass spectrometry and structural modeling.
    Zhang A; Hu P; MacGregor P; Xue Y; Fan H; Suchecki P; Olszewski L; Liu A
    Anal Chem; 2014 Apr; 86(7):3468-75. PubMed ID: 24597564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the utility of minimized sample preparation and high-resolution mass spectrometry for quantification of monoclonal antibody drugs.
    Nguyen TTTN; Mistarz UH; Costa N; Herbet A; Boquet D; Becher F; Rand KD
    J Pharm Biomed Anal; 2018 Sep; 159():384-392. PubMed ID: 30071466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-State NMR Characterization of Lyophilized Formulations of Monoclonal Antibody Therapeutics.
    Perodeau J; Arbogast LW; Nieuwkoop AJ
    Mol Pharm; 2023 Mar; 20(3):1480-1489. PubMed ID: 36702622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of High Resolution 2D NMR Fingerprinting in Assessing Viscosity of Therapeutic Monoclonal Antibodies.
    Majumder S; Bhattacharya DS; Langford A; Ignatius AA
    Pharm Res; 2022 Mar; 39(3):529-539. PubMed ID: 35174433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of standard accelerated stability conditions on antibody higher order structure as assessed by mass spectrometry.
    Kerr RA; Keire DA; Ye H
    MAbs; 2019 Jul; 11(5):930-941. PubMed ID: 30913973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of NMR in High Ordered Structure Characterization of Monoclonal Antibodies.
    Tokunaga Y; Takeuchi K
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a rapid RP-UHPLC-MS method for analysis of modifications in therapeutic monoclonal antibodies.
    Zhang B; Jeong J; Burgess B; Jazayri M; Tang Y; Taylor Zhang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():172-181. PubMed ID: 27233581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.